cor2ed
engage checkpoint medical linkedin twitter
bg

Treatment sequencing in metastatic renal cell carcinoma (mRCC)

Treatment sequencing in metastatic renal cell carcinoma (mRCC)

Dr Roberto Iacovelli

Dr Roberto Iacovelli brings you his interpretation of the data when deciding upon the best approach to treatment sequencing in mRCC.

Portrait of Roberto Iacovelli
Dr Roberto Iacovelli

Medical Oncologist

Fondazione Policlinico Gemelli IRCCS

Italy

preview next

time | open 5 min | Oct 2021

download resources

This programme was made for you:   your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

GU CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca, Bayer and Eisai Europe Limited.

Other programmes of interest